日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Diagnostic Value of Cell-Free DNA Fetal Fraction in Patients With Prenatally Suspected Placenta Accreta Spectrum Disorder

无细胞DNA胎儿片段在产前疑似胎盘植入谱系障碍患者中的诊断价值

Chirumbole, Danielle; Parobek, Christian M; Tai, Alex; Sangi-Haghpeykar, Haleh; Mendez, Yamely H; Kamepalli, Spoorthi; Reed, Christina C; Ladron de Guevara, Arthur; Lane, Keneshia; Hoppenot, Claire; Shamshirsaz, Amir A; Belfort, Michael A; Munoz, Jessian L; Lombaard, Hendrik A

The 96-week outcomes and pharmacokinetics of long-acting cabotegravir plus rilpivirine in South Africans

南非人接受长效卡博特韦加利匹韦林治疗96周的疗效和药代动力学研究

Mngqibisa, Rosie; Singh, Yashna; Orrell, Catherine; Lombaard, Johan; Griffith, Sandy; Harrington, Conn; D'Amico, Ronald; Spreen, William; St Clair, Marty; Latham, Christine; Garside, Louise; Van Solingen-Ristea, Rodica; Van Eygen, Veerle; Boateng, Fafa Addo; Crauwels, Herta; Eneh, Prosperity; Eshun-Wilsonova, Ingrid

[Establishment and clinical application effects of a three-dimensional navigation process for design and resection of perforator flaps based on multi-detector computed tomography angiography]

[基于多层螺旋CT血管造影的三维导航穿支皮瓣设计与切除术的建立及临床应用效果]

Akelina, Yelena; Lombaard, Jan B; Coleman, Nicholas J; Abboud, Joseph; 尹, 其翔; 糜, 菁熠; 蔡, 华忠; 周, 峰; 姚, 群; 华, 雍

Pharmacokinetics, Safety and Antiviral Activity of Rilpivirine in Antiretroviral-naïve Children With HIV ≥6 to <12 Years Old: Week 48 and Final Analysis of Cohort 2 From the Open-label, Phase 2 PAINT Study

利匹韦林在既往未接受过抗逆转录病毒治疗的 HIV 感染儿童(≥6 岁至 <12 岁)中的药代动力学、安全性和抗病毒活性:开放标签 II 期 PAINT 研究第 2 组队列第 48 周和最终分析

Lombaard, Johan; Moolasart, Visal; Lutaakome, Joseph; Van Solingen-Ristea, Rodica; Van Eygen, Veerle; Van Hemelryck, Sandy; Foulkes, Sharne; Natukunda, Eva; Kurosawa, Ken; Shibuya, Minaka; Vanveggel, Simon; Van Landuyt, Erika; Ssali, Francis

Safety, Tolerability, and Pharmacokinetics of Once-Monthly Oral Islatravir: A Phase 2a Study in Participants at Low Risk for Acquiring Human Immunodeficiency Virus Type 1

每月一次口服伊斯拉曲韦的安全性、耐受性和药代动力学:一项针对1型人类免疫缺陷病毒感染低风险人群的2a期研究

Hillier, Sharon L; Bekker, Linda-Gail; Riddler, Sharon A; Hendrix, Craig W; Badal-Faesen, Sharlaa; Macdonald, Pippa; Nair, Gonasagrie; Lombaard, Johannes; Caraco, Yoseph; Peer, Avivit; Patel, Munjal; Vargo, Ryan; Homony, Brenda; Nedrow, Katherine; Evans, Barbara; Wickremasingha, Prachi; Zhou, Yun-Ping; Teal, Valerie; Hwang, Peggy; McMullan, Ciaran; Kaufman, Keith D; Robertson, Michael N; Plank, Rebeca M

Subcutaneous injections of cabotegravir plus rilpivirine long-acting in virally suppressed adults with HIV-1

对病毒载量受到抑制的 HIV-1 感染成人进行卡博特韦联合利匹韦林长效制剂的皮下注射

D'Amico, Ronald; Han, Kelong; Min, Sherene; DeMoor, Rebecca; St Clair, Marty; Ford, Susan L; Harrington, Conn; Bernal-Morell, Enrique; Lombaard, Johannes; Crauwels, Herta; Kolobova, Irina; Patel, Natasha; Jamil, Nasir; Van Solingen-Ristea, Rodica; Acuipil, Carolina; Spreen, William

Immunogenicity and safety following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine with Matrix-M(TM) adjuvant (NVX-CoV2373) versus a primary series in people living with and without HIV-1 infection in South Africa: A randomized crossover phase 2a/2b trial

在南非,一项随机交叉2a/2b期试验评估了SARS-CoV-2重组刺突蛋白疫苗(含Matrix-M™佐剂,NVX-CoV2373)加强剂与基础免疫接种相比,在HIV-1感染者和未感染者中的免疫原性和安全性。

Shinde, Vivek; Lombard Koen, Anthonet; Hoosain, Zaheer; Archary, Moherndran; Bhorat, Qasim; Fairlie, Lee; Lalloo, Umesh; Masilela, Mduduzi S L; Moodley, Dhayendre; Hanley, Sherika; Fouche, Leon Frederik; Louw, Cheryl; Tameris, Michele; Singh, Nishanta; Goga, Ameena; Dheda, Keertan; Grobbelaar, Coert; Joseph, Natasha; Lombaard, Johan J; Mngqibisa, Rosie; Bhorat, As'ad Ebrahim; Benadé, Gabriella; Lalloo, Natasha; Pitsi, Anna; Vollgraaff, Pieter-Louis; Luabeya, Angelique; Esmail, Aliasgar; Petrick, Friedrich G; Oommen Jose, Aylin; Foulkes, Sharne; Ahmed, Khatija; Thombrayil, Asha; Kalonji, Dishiki; Cloney-Clark, Shane; Zhu, Mingzhu; Bennett, Chijioke; Albert, Gary; Marcheschi, Alex; Plested, Joyce S; Neal, Susan; Chau, Gordon; Cho, Iksung; Fries, Louis; Glenn, Greg M; Madhi, Shabir A

Perinatal mental healthcare utilization among patients with placenta accreta spectrum

胎盘植入谱系患者围产期心理健康保健利用情况

Casey, Sarah R; Goulding, Alison N; Reed, Christina C; Shamshirsaz, Amir A; Lombaard, Hennie A; Belfort, Michael A; Noll, Lisa M; Fox, Karin A

Safety, effectiveness and immunogenicity of heterologous mRNA-1273 boost after prime with Ad26.COV2.S among healthcare workers in South Africa: The single-arm, open-label, phase 3 SHERPA study

在南非医护人员中,使用Ad26.COV2.S初次免疫后,异源mRNA-1273加强免疫的安全性、有效性和免疫原性:单臂、开放标签、3期SHERPA研究

Garrett, Nigel; Reddy, Tarylee; Yende-Zuma, Nonhlanhla; Takalani, Azwidhwi; Woeber, Kubashni; Bodenstein, Annie; Jonas, Phumeza; Engelbrecht, Imke; Jassat, Waasila; Moultrie, Harry; Bradshaw, Debbie; Seocharan, Ishen; Odhiambo, Jackline; Khuto, Kentse; Richardson, Simone I; Omondi, Millicent A; Nesamari, Rofhiwa; Keeton, Roanne S; Riou, Catherine; Moyo-Gwete, Thandeka; Innes, Craig; Zwane, Zwelethu; Mngadi, Kathy; Brumskine, William; Naicker, Nivashnee; Potloane, Disebo; Badal-Faesen, Sharlaa; Innes, Steve; Barnabas, Shaun; Lombaard, Johan; Gill, Katherine; Nchabeleng, Maphoshane; Snyman, Elizma; Petrick, Friedrich; Spooner, Elizabeth; Naidoo, Logashvari; Kalonji, Dishiki; Naicker, Vimla; Singh, Nishanta; Maboa, Rebone; Mda, Pamela; Malan, Daniel; Nana, Anusha; Malahleha, Mookho; Kotze, Philip; Allagappen, Jon J; Diacon, Andreas H; Kruger, Gertruida M; Patel, Faeezah; Moore, Penny L; Burgers, Wendy A; Anteyi, Kate; Leav, Brett; Bekker, Linda-Gail; Gray, Glenda E; Goga, Ameena

Hereditary angioedema and COVID-19 during pregnancy: Two case reports

妊娠期遗传性血管性水肿合并新冠肺炎:两例病例报告

Salih, Amanda; Chin, Aaron; Gandhi, Manisha; Shamshirsaz, Amir; Lombaard, Hennie; Hajjar, Joud